ArticleCancer immunology, immunotherapy : CII2013

Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.

Martin J Cannon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.